skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

Between October 1980 and July 1983, 13 patients with clinical Stage II Hodgkin's disease who had a large mediastinal mass were entered into a prospective treatment program emphasizing irradiation. Careful clinical staging, including CT scanning, was completed in order to define precisely the extent of disease in the chest. The range of MMR was .34 to .56. By the time mantle irradiation was completed the MMR ranged from .21 to .35. Twelve patients underwent laparotomy after adequate reduction of the mediastinal mass size, but only two had subdiaphgragmatic disease detected. One patient had disease extension into the lung during mantle irradiation and one patient failed in a rib six months after completion of irradiation. Both have been treated successfully with salvage chemotherapy. All the remaining patients received prophylactic irradiation below the diaphragm and all are doing well with a median follow up of 21 months. The 2 year actuarial freedom from relapse of the entire group of 13 patients is 83%. These early results are very encouraging for this unfavorable group of patients with large mediastinal masses. Careful monitoring of tumor response and use of a shrinking field technique has helped to keep complications to a minimum.

Research Organization:
Stanford Univ. School of Medicine, CA
OSTI ID:
5606164
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 11:2
Country of Publication:
United States
Language:
English

Similar Records

Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure
Journal Article · Mon Jun 01 00:00:00 EDT 1987 · Am. J. Clin. Oncol.; (United States) · OSTI ID:5606164

Therapeutic utility of lung irradiation for Hodgkin's disease patients with large mediastinal masses
Conference · Sun Feb 01 00:00:00 EST 1981 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5606164

NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease
Journal Article · Sat Dec 01 00:00:00 EST 1990 · Seminars in Oncology; (USA) · OSTI ID:5606164